We are delighted to announce our 6th annual Oxford Symposium on antisense and therapeutic oligonucleotides.
The symposium is aimed at bringing together chemists and biologists from academia and industry to discuss the latest advances and breakthroughs in the development of synthetic oligonucleotides as therapeutics.
The symposium agenda is currently in progress and we welcome proposals for oral and poster presentation on THERAPEUTIC APPLICATIONS AND DELIVERY STRATEGIES of synthetic oligonucleotides, including:
>Antisense & catalytic oligonucloetides, aptamers, siRNAs, miRNAs, antagomirs
>Chemical modifications
>In vitro/in vivo applications
>Delivery strategies
>New technologies
We particularly encourage final year doctoral students and early/mid-career postdoctoral researchers/junior group leaders to submit oral and poster abstracts (abstract submission is now closed), as we believe this event will provide their research an excellent exposure, critical analysis by attending senior researchers and new career opportunities. Please contact us on OLIGOMER@LPMHealthcare.com with your presentation theme/abstract for pre-approval, or if you have any other questions.
For further information, please visit: http://lpmhealthcare.com/oligo-2020-oxford
